Sintilimab Combined with Bevacizumab in Relapsed or Persistent Ovarian Clear Cell Carcinoma (INOVA): a Multicentre, Single-Arm, Phase 2 Trial
The Lancet Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined